Peer review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help Editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.
Molecular Cancer operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.
The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will be screened for suitability for Molecular Cancer by one of the journal's Editors-in-Chief and appropriate manuscripts will be sent for peer-review. Peer-reviewers are selected by appropriate Associate Editors. Decisions will be made based upon at least two reviewer reports.
2017 Journal Metrics
64 days to first decision for reviewed manuscripts only
46 days to first decision for all manuscripts
150 days from submission to acceptance
16 days from acceptance to publication
Social Media Impact